Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Flavonoids against the SARS-CoV-2 induced inflammatory storm
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111430-111430
Open Access | Times Cited: 132

Showing 26-50 of 132 citing articles:

Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
Kevin Zhai, Alena Mazuráková, Lenka Koklesová, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1841-1841
Open Access | Times Cited: 49
Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Foods (2022) Vol. 11, Iss. 18, pp. 2884-2884
Open Access | Times Cited: 33
Ginkgo biloba in the management of the COVID‐19 severity
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 10
Open Access | Times Cited: 27
Potential interaction between the oral microbiota and COVID-19: a meta-analysis and bioinformatics prediction
Li Tan, Meng‐Mei Zhong, Qiong Liu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 14
Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications
M. Gallorini, Simone Carradori, Emiliano Panieri, et al.
Antioxidants and Redox Signaling (2023) Vol. 40, Iss. 10-12, pp. 636-662
Closed Access | Times Cited: 14
Inhibitory effects of sulforaphane on NLRP3 inflammasome activation
Cagla Kiser, Ceren Perihan Gonul, Melis Olcum, et al.
Molecular Immunology (2021) Vol. 140, pp. 175-185
Closed Access | Times Cited: 34
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Khojasteh Malekmohammad, Mahmoud Rafieian‐Kopaei
Current Pharmaceutical Design (2021) Vol. 27, Iss. 38, pp. 3996-4007
Closed Access | Times Cited: 33
Functional constituents of plant-based foods boost immunity against acute and chronic disorders
Waseem Khalid, Muhammad Sajid Arshad, Muhammad Modassar Ali Nawaz Ranjha, et al.
Open Life Sciences (2022) Vol. 17, Iss. 1, pp. 1075-1093
Open Access | Times Cited: 24
The Protective Effect of Mulberry Leaf Flavonoids on High-Carbohydrate-Induced Liver Oxidative Stress, Inflammatory Response and Intestinal Microbiota Disturbance in Monopterus albus
Yong Shi, Lei Zhong, Yuding Fan, et al.
Antioxidants (2022) Vol. 11, Iss. 5, pp. 976-976
Open Access | Times Cited: 23
Systems pharmacology-based drug discovery and active mechanism of natural products for coronavirus pneumonia (COVID-19): An example using flavonoids
Bin Wang, Yan Ding, Penghui Zhao, et al.
Computers in Biology and Medicine (2022) Vol. 143, pp. 105241-105241
Open Access | Times Cited: 22
Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials
Jia Yao, Yuan Zhang, Xian-Zhe Wang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 22
PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection
V. S. Lekshmi, Kumari Asha, Melvin Sanicas, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 13
Treating COVID-19 with Medicinal Plants: Is It Even Conceivable? A Comprehensive Review
Hadi Al-Jamal, Sara Idriss, Rabih Roufayel, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 320-320
Open Access | Times Cited: 3
Synthesis of Flavonols and Assessment of Their Biological Activity as Anticancer Agents
Yu-Hui Hsieh, Pei-Hsuan Hsu, Anren Hu, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2041-2041
Open Access | Times Cited: 3
Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study
Mohammed Baqur S. Al‐Shuhaib, Hayder O. Hashim, Jafar M. B. Al‐Shuhaib
Computers in Biology and Medicine (2021) Vol. 141, pp. 105155-105155
Open Access | Times Cited: 28
Therapeutic Potential of Glycosyl Flavonoids as Anti-Coronaviral Agents
Patrícia I. C. Godinho, Raquel G. Soengas, Vera L. M. Silva
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 546-546
Open Access | Times Cited: 27
Some Flavolignans as Potent Sars-Cov-2 Inhibitors via Molecular Docking, Molecular Dynamic Simulations and ADME Analysis
Adnan Çetin
Current Computer - Aided Drug Design (2022) Vol. 18, Iss. 5, pp. 337-346
Closed Access | Times Cited: 20
Flavonoids from Siparuna cristata as Potential Inhibitors of SARS-CoV-2 Replication
Carla Monteiro Leal, Suzana Guimarães Leitão, Romain Sausset, et al.
Revista Brasileira de Farmacognosia (2021) Vol. 31, Iss. 5, pp. 658-666
Open Access | Times Cited: 25
Antioxidant, molecular docking and computational investigation of new flavonoids
Affifa Tajammal, Aysha Siddiqa, Ahmad Irfan, et al.
Journal of Molecular Structure (2021) Vol. 1254, pp. 132189-132189
Closed Access | Times Cited: 25
Remodeling the Epigenetic Landscape of Cancer—Application Potential of Flavonoids in the Prevention and Treatment of Cancer
Weiyi Jiang, Tingting Xia, Cun Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23
Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-COV-2
Saba Rahimi Bahoosh, Yalda Shokoohinia, Mahdieh Eftekhari
DARU Journal of Pharmaceutical Sciences (2022) Vol. 30, Iss. 1, pp. 245-252
Open Access | Times Cited: 17
Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive Decline
James Melrose, Margaret M. Smith
Frontiers in Bioscience-Elite (2022) Vol. 14, Iss. 4, pp. 27-27
Open Access | Times Cited: 16
Anti-SARS-CoV-2 Activity of Ampelozizyphus amazonicus (Saracura-Mirá): Focus on the Modulation of the Spike-ACE2 Interaction by Chemically Characterized Bark Extracts by LC-DAD-APCI-MS/MS
Mariana Freire Campos, Simony Carvalho Mendonça, Evelyn Maribel Condori Peñaloza, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3159-3159
Open Access | Times Cited: 9
Natural Products as a Potential Source of Promising Therapeutics for COVID‐19 and Viral Diseases
Soheila Bafandeh, Ehsaneh Khodadadi, Khudaverdi Ganbarov, et al.
Evidence-based Complementary and Alternative Medicine (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 9
Antiviral and Possible Prophylactic Significance of Myricetin for COVID-19
Pawan K. Agrawal, Chandan Agrawal, Gerald Blunden
Natural Product Communications (2023) Vol. 18, Iss. 4
Open Access | Times Cited: 8

Scroll to top